T81.9
Conditions
Interventions
Group 1: As part of routine intervention, the patient is hospitalized.
The inclusion criteria for the planned recruitment are evaluated by present CT or MRI imaging. Immediately prior to treatment,
Sponsors
Klinikum der Universität München, Campus Großhadern
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - Existence of postoperative clinically relevant LL with indication for intervention - Therapy resistance to conservative treatment options (parenteral nutrition, percutaneous drainage, middle-chain triglyceride diet) - present lymph nodes / lymphatic vessels / lymphatic leak - platelets> 50,000 / mm3 (50 GPt / l) - PTT-INR / PTT> 1.5 times upper limit (patients taking anticoagulants may be included if no underlying blood clotting abnormality has previously been detected) - Signed informed consent - Age> 18 years
Exclusion criteria
Exclusion criteria: - Severe pulmonary insufficiency - Heart defect with right-left shunt - Contraindications to treatment with Lipiodol - contraindications to lymphography - platelets <50,000 / mm3 (50 GPt / l) - PTT-INR / PTT <1.5 times the upper standard value - abnormality of blood clotting
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lipiodol use during routine lymphatic drainage. | — |
Secondary
| Measure | Time frame |
|---|---|
| Detection of lymphatic leaks using lipiodol in the context of study-controlled data acquisition. Evidence of leakage during clinical routine follow-up by ultrasound or MRI or if clinically indicated by a CT scan. | — |
Countries
Germany
Contacts
Public ContactChristel Besseler
Klinikum der Universität München Klinik und Poliklinik für Radiologie
Outcome results
None listed